Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study

AJR Am J Roentgenol. 2011 Aug;197(2):W343-5. doi: 10.2214/AJR.10.6019.

Abstract

Objective: Abscess formation is a common serious adverse event after intraarterial therapy for hepatic malignancy in patients with colonized bile ducts. The combination of antibiotic prophylaxis and bowel preparation has been used to prevent hepatic abscess. We describe our outcomes with moxifloxacin prophylaxis alone without bowel preparation.

Conclusion: Ten patients underwent 25 procedures and were followed for a median of 250 days. No abscesses developed. Our results suggest moxifloxacin alone may suffice for prophylaxis.

MeSH terms

  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use*
  • Antibiotic Prophylaxis*
  • Antineoplastic Agents / administration & dosage
  • Aza Compounds / administration & dosage
  • Aza Compounds / therapeutic use*
  • Biliary Tract Diseases / therapy
  • Case-Control Studies
  • Chemoembolization, Therapeutic
  • Embolization, Therapeutic / methods*
  • Ethiodized Oil / administration & dosage
  • Female
  • Fluoroquinolones
  • Humans
  • Liver Abscess / prevention & control*
  • Liver Neoplasms / therapy*
  • Male
  • Moxifloxacin
  • Pilot Projects
  • Quinolines / administration & dosage
  • Quinolines / therapeutic use*
  • Radiography, Interventional
  • Retrospective Studies
  • Risk Factors

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Ethiodized Oil
  • Moxifloxacin